Industry Perspectives

Unified data platforms are key to breaking down silos, improving data accessibility, and enabling more efficient, accurate, and predictive workflows across the drug development lifecycle.

Agilent debuts LC/MS and GC/MS innovations at ASMS 2025, advancing lab efficiency, sustainability, and analytical performance.

With the launch of the ZenoTOF 8600 system and new software partnerships, SCIEX advances accurate mass quantitation by delivering unprecedented sensitivity, speed, and data clarity across all omics disciplines.

Orbitrap Astral Zoom and Orbitrap Excedion Pro deliver increased speed and sensitivity to set a new performance benchmark for high-resolution, accurate mass spectrometry.

The timsOmni™ uniquely enables protein researchers and biologics developers to tailor information-rich dissociation pathways for deeper insights - with high speed and high sensitivity.

The new system is designed to deliver exceptional performance for the most sensitive trace-level analyses in complex matrices, while maximizing system uptime and efficiency.

The timsMetabo™ system enables the generation of a ‘digital metabolome archive’ for every sample.

Recent advancements in imaging technologies are transforming spatial proteomics by enhancing data throughput, resolution, and multiplexing capabilities.

Acquisition supports TQ Therapeutics’ development of ultra-short extracorporeal cell and gene therapy platform

Dermaliq’s proprietary hyliQ® technology platform enables touchless delivery of novel drug therapies to fragile, sensitive or disease-affected skin.

Collaboration allows researchers to progress rapidly from DNA to purified and characterized protein, to facilitate insights into drug-target interactions

Pharmaceutical companies are investing in supply chain visibility, ethical sourcing, and proactive strategies to build resilience and protect patient access.